XML 27 R14.htm IDEA: XBRL DOCUMENT v3.25.3
Intellectual Property net
9 Months Ended 12 Months Ended
May 31, 2025
Aug. 31, 2024
Intellectual Property net    
Intellectual Property. net

7. Intellectual Property, net

 

A continuity schedule for capitalized patents is presented below:

 

 

 

May 31,

 

 

August 31,

 

 

 

2025

 

 

2024

 

Balance – beginning

 

$516,676

 

 

$462,625

 

Additions

 

 

60,496

 

 

 

145,591

 

Impairment

 

 

(33,540 )

 

 

(57,836 )

Amortization

 

 

(27,212 )

 

 

(33,704 )

Balance – ending

 

$516,420

 

 

$516,676

 

 

The Company evaluated its patent portfolio to determine whether certain pending applications had been abandoned or will not be pursued. During the nine months ended May 31, 2025, the Company recognized an impairment loss of $33,540 related to those abandoned applications.  The Company recognized $27,212 of amortization expense related to patents and licenses in the nine months ended May 31, 2025.

 

The following table summarizes expected future amortization of the Company’s patent portfolio as of May 31, 2025:

 

Fiscal Years Ending August 31,

 

 

 

2025

 

$25,821

 

2026

 

 

25,821

 

2027

 

 

25,821

 

2028

 

 

25,821

 

2029

 

 

25,821

 

Thereafter

 

 

387,315

 

Total

 

$516,420

 

7. Intellectual Property, net

 

A continuity schedule for capitalized patents is presented below:

 

 

 

August 31,

 

 

August 31,

 

 

 

2024

 

 

2023

 

Balance – beginning

 

$462,625

 

 

$488,462

 

Addition

 

 

145,591

 

 

 

135,862

 

Impairment

 

 

(57,836)

 

 

(106,761)

Amortization

 

 

(33,704)

 

 

(54,938)

Balance – ending

 

$516,676

 

 

$462,625

 

 

The Company evaluated its patent portfolio and determined that certain pending applications had been abandoned or will not be pursued. As such, during the year ended August 31, 2024, the Company recognized an impairment loss of $57,836 related to those abandoned applications.  The Company recognized $33,704 of amortization expense related to patents and licenses in the year ended August 31, 2024.

 

The following table summarizes expected future amortization of the Company’s patent portfolio as of August 31, 2024:

 

Years Ending December 31,

 

 

 

2025

 

$25,813

 

2026

 

 

25,813

 

2027

 

 

25,813

 

2028

 

 

25,813

 

2029

 

 

25,813

 

Thereafter

 

$387,611

 

Total

 

$516,676